UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------- ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q2 2021 Earnings Conference Call August 9, 2021 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Scott Tariff – Chief Executive Officer Judith Ng-Cashin – Chief Medical Officer Brian Cahill – Chief Financial Officer Conference Call Participants Brandon Folkes – Cantor Fitzgerald Tim Lugo – William Blair Steve Arthur – RBC Capital Markets Jack Hendricks – Piper Sandler Operator Good morning, everyone. My name is Keith and I will be your conference O ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|--------------------------------------------------- ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q1 2021 Earnings Conference Call May 10, 2021 8:30 AM ET Company Participants Lisa Wilson - Investor Relations Scott Tarriff - Chief Executive Officer Brian Cahill - Chief Financial Officer Conference Call Participants Tim Lugo - William Blair Daniel Busby - RBC Capital Markets David Amsellem - Piper Sandler Brandon Folkes - Cantor Fitzgerald Operator Good morning, everyone. My name is Leo, and I will be your conference operator. At this time, I’d like to welcome ev ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|-------------------------------------------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | --- | --- | --- | |----------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------| | | For the transition period from to . \nCommission File Number 001-36306 Eagle Pharmaceuticals, Inc. ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q4 2020 Earnings Conference Call March 2, 2021 8:30 AM ET Company Participants Lisa Wilson - IR Scott Tarriff - CEO Brian Cahill - CFO David Pernock - President and COO Judith Ng-Cashin - Chief Medical Officer Conference Call Participants Randall Stanicky - RBC Capital Markets Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Operator Good morning, everyone. My name is Leo. And I'll be your conference operator. At this time, I'd like to welcome everyone to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------- ...

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q3 2020 Earnings Conference Call November 2, 2020 8:30 AM ET Company Participants Lisa Wilson - IR Scott Tarriff - CEO Brian Cahill - CFO David Pernock - President and COO Conference Call Participants Randall Stanicky - RBC Capital Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Gregg Gilbert - Truist Operator Good morning, everyone. My name is Reed, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ____________ Commission File Number 001-36306 Eagle Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 2834 20-8179278 (St ...